Revvity Inc
(BSP:R1VT34)
R$
23.77
0 (0%)
Market Cap: 81.00 Bil
Enterprise Value: 93.46 Bil
PE Ratio: 56.19
PB Ratio: 1.79
GF Score: 65/100 PerkinElmer Inc at Robert W Baird Global Healthcare Conference Transcript
Sep 10, 2020 / 12:30PM GMT
Release Date Price:
R$23.84
Catherine Walden Ramsey Schulte
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
All right. We'll go ahead and get started. Thanks, everyone, for joining us today. I'm Catherine Schulte. I cover Life Sciences and Diagnostics here at Baird. We're very excited to have PerkinElmer here presenting with us today. Representing the company, we have the CFO, Jamie Mock; and the Vice President of IR, Bryan Kipp. So thanks so much to both of you for being here.
James M. Mock
PerkinElmer, Inc. - Senior VP & CFO
Thanks, Catherine.
Questions & Answers
Catherine Walden Ramsey Schulte
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
As far as the agenda today, we're going to dive right into Q&A. So if anyone in the audience has a question, please submit them through the web portal, and we will work them into our conversation. So with that, maybe just first, Jamie, for those who might not be as familiar with your business. Can you just give
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot